deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06057129

Unsupervised Therapy After Stroke in the Home Setting with a Hand Rehabilitation Device (ReHandyBot)

Feasibility of Unsupervised Therapy After Stroke in the Home Setting with a Hand Rehabilitation Device (ReHandyBot): an Exploratory Study

Sponsor: Clinica Hildebrand Brissago

Conditions Stroke
Updated 7 times since 2023 Last updated: Oct 30, 2024 Started: Nov 13, 2023 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Stroke and is currently actively recruiting participants. Clinica Hildebrand Brissago leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2023 – ~Dec 2023 · 2 months · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshotRecruiting~Apr 2025 – present · 16 months · monthly snapshotRecruiting

Change History

7 versions recorded
  1. Apr 2025 — Present [monthly]

    Recruiting NA

  2. Dec 2024 — Apr 2025 [monthly]

    Recruiting NA

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jan 2024 — Jul 2024 [monthly]

    Recruiting NA

Show 2 earlier versions
  1. Dec 2023 — Jan 2024 [monthly]

    Recruiting NA

  2. Oct 2023 — Dec 2023 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinica Hildebrand Brissago
  • Swiss Federal Institute of Technology
Data source: Swiss Federal Institute of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations